Table I.
Number of non-persistent antibodies.
| Antibody | N | % * | Non- persistent | % ** |
|---|---|---|---|---|
| E | 136 | 20.2 | 53 | 39.0 |
| K | 118 | 17.5 | 40 | 33.9 |
| D | 108 | 16.0 | 15 | 13.9 |
| ? | 57 | 8.5 | 44 | 77.2 |
| C | 38 | 5.6 | 9 | 23.7 |
| c | 36 | 5.3 | 8 | 22.2 |
| Jka | 30 | 4.5 | 13 | 43.3 |
| M | 25 | 3.7 | 7 | 28.0 |
| Cw | 24 | 3.6 | 13 | 54.2 |
| Fya | 19 | 2.8 | 4 | 21.1 |
| Lea | 14 | 2.1 | 8 | 57.1 |
| Leb | 10 | 1.5 | 6 | 60.0 |
| S | 10 | 1.5 | 5 | 50.0 |
| Kpa | 9 | 1.3 | 3 | 33.3 |
| Wra | 8 | 1.2 | 5 | 62.5 |
| Lua | 7 | 1.0 | 4 | 57.1 |
| e | 6 | 0.9 | 3 | 50.0 |
| Jkb | 6 | 0.9 | 3 | 50.0 |
| Cob | 2 | 0.3 | 1 | 50.0 |
| N | 2 | 0.3 | 2 | 100.0 |
| cE | 1 | 0.1 | 1 | 100.0 |
| Cha | 1 | 0.1 | 1 | 100.0 |
| Dia | 1 | 0.1 | 1 | 100.0 |
| f | 1 | 0.1 | 0 | 0.0 |
| Fyb | 1 | 0.1 | 0 | 0.0 |
| Jsa | 1 | 0.1 | 1 | 100.0 |
| Lub | 1 | 0.1 | 0 | 0.0 |
| Xga | 1 | 0.1 | 1 | 100.0 |
| Total | 673 | 100 | 251 | 37.3 |
The antibodies are listed in order of frequency.
‘?’ indicates that the specificity was not identified with certainty (auto- and pan-antibodies were excluded). Anti-D from women of childbearing age were also excluded because it was impossible to rule out Rh prophylaxis.
*
Percentage with respect to the total number of antibodies
**
Percentage of non-persistent antibodies, with respect to the number of antibodies with the same specificity.